Anixa Biosciences | 8-K: Current report
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Baskies Arnold M
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer KUMAR AMIT
Anixa Biosciences | 10-Q: Quarterly report
Anixa Biosciences | DEF 14A: Definitive information statements
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Baskies Arnold M
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Gottschalk Emily
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Catelani Michael
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Titterton Lewis H jr
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer KUMAR AMIT
Anixa Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Amit Kumar(13.5%)
Anixa Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Anixa Biosciences | 10-K: Annual report
Anixa Biosciences | 8-K: Current report
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Catelani Michael
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Titterton Lewis H jr
Anixa Biosciences | 10-Q: Q3 2023 Earnings Report
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Titterton Lewis H jr
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer KUMAR AMIT
Anixa Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Catelani Michael
No Data